Of note, while severe courses of COVID-19 correlate with high levels of SARS-CoV-2-specific antibodies during and after disease, an early generation of strong virus-specific CD4+ and CD8+ T cell responses is associated with milder symptoms [41,44,45]. This evidence concerns the gene CD4 and COVID-19.